Literature DB >> 23073824

Micafungin for Candida albicans pacemaker-associated endocarditis: a case report and review of the literature.

Carlo Tascini1, Maria Grazia Bongiorni, Enrico Tagliaferri, Antonello Di Paolo, Sarah Flammini, Ezio Soldati, Alessandro Leonildi, Andrea Di Cori, Francesco Menichetti.   

Abstract

We report on the treatment with micafungin of a pacemaker-associated endocarditis due to Candida albicans. Antifungal therapy was able to reduce vegetation size from 5 to 1 cm making possible the transvenous removal of the device without a high risk of pulmonary embolism. Noteworthy, a high micafungin concentration was documented into the lead vegetation (10 μg/g of vegetation tissue) and this may have contributed to the striking size reduction of vegetation.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23073824     DOI： 10.1007/s11046-012-9591-2

Source DB:  PubMed          Journal:  Mycopathologia        ISSN： 0301-486X            Impact factor:   2.574


  42 in total

1.  Diagnostic challenges in native valve fungal endocarditis producing a massive septic pulmonary embolus.

Authors:  Darren Salmi; Aarti Bhat; Larry Corman; Gary Raff; Noriko Satake
Journal:  Nihon Ishinkin Gakkai Zasshi       Date:  2010

2.  Requirement for Candida albicans Sun41 in biofilm formation and virulence.

Authors:  Carmelle T Norice; Frank J Smith; Norma Solis; Scott G Filler; Aaron P Mitchell
Journal:  Eukaryot Cell       Date:  2007-09-14

3.  In vitro activity of anidulafungin against Candida albicans biofilms.

Authors:  Melissa J Jacobson; Kerryl E Piper; Gary Nguyen; James M Steckelberg; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2008-04-07       Impact factor: 5.191

4.  Successful percutaneous extraction of pacemaker leads with a novel (VascoExtor) pacing lead removal system.

Authors:  A S Manolis; T N Maounis; J Chiladakis; V Vassilikos; H Melita-Manolis; D V Cokkinos
Journal:  Am J Cardiol       Date:  1998-04-01       Impact factor: 2.778

5.  Management of cardiac device infections: A retrospective survey of a non-surgical approach combining antibiotic therapy with transvenous removal.

Authors:  C Tascini; M G Bongiorni; G Gemignani; E Soldati; A Leonildi; G Arena; R Doria; G Giannola; F La Pira; E Tagliaferri; P Caravelli; R Dell'Anna; F Menichetti
Journal:  J Chemother       Date:  2006-04       Impact factor: 1.714

6.  In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies.

Authors:  Gordon Ramage; Kacy VandeWalle; Stefano P Bachmann; Brian L Wickes; José L López-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

7.  Complications with retained transvenous pacemaker electrodes.

Authors:  G Rettig; P Doenecke; S Sen; I Volkmer; L Bette
Journal:  Am Heart J       Date:  1979-11       Impact factor: 4.749

8.  Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections.

Authors:  Muhammad R Sohail; Daniel Z Uslan; Akbar H Khan; Paul A Friedman; David L Hayes; Walter R Wilson; James M Steckelberg; Sarah Stoner; Larry M Baddour
Journal:  J Am Coll Cardiol       Date:  2007-04-23       Impact factor: 24.094

Review 9.  Pacemaker endocarditis. Report of 44 cases and review of the literature.

Authors:  N Arber; E Pras; Y Copperman; J M Schapiro; V Meiner; I S Lossos; A Militianu; D Hassin; E Pras; A Shai
Journal:  Medicine (Baltimore)       Date:  1994-11       Impact factor: 1.889

10.  Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association.

Authors:  Larry M Baddour; Andrew E Epstein; Christopher C Erickson; Bradley P Knight; Matthew E Levison; Peter B Lockhart; Frederick A Masoudi; Eric J Okum; Walter R Wilson; Lee B Beerman; Ann F Bolger; N A Mark Estes; Michael Gewitz; Jane W Newburger; Eleanor B Schron; Kathryn A Taubert
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690
View more
  4 in total

1.  The characteristics and outcome of infective endocarditis involving implantable cardiac devices.

Authors:  Eugene Athan
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

2.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

3.  First Reported Case of Candida dubliniensis Endocarditis Related to Implantable Cardioverter-Defibrillator.

Authors:  Nooraldin Merza; John Lung; Taryn B Bainum; Assad Mohammedzein; Shanna James; Mazin Saadaldin; Tarek Naguib
Journal:  Case Rep Cardiol       Date:  2020-01-16

4.  Pacemaker lead Candida endocarditis: Is medical treatment possible?

Authors:  Syamasis Bandyopadhyay; P K Tiwary; Susobhan Mondal; Shilpa Puthran
Journal:  Indian Heart J       Date:  2015-12-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.